Sponsor Pipeline

Crossbow Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06994676 A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias High-risk Myelodysplastic Syndrome Recruiting
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Chronic Myeloid Leukemia (CML) (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Crossbow Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free